BioAge Labs, Inc BIOA IPO will take place September, 26 on the NASDAQ exchange under the ticker BIOA.

The company is offering shares at an expected price between $17.00 and $19.00 per share with an insider lock-up period of 180 days ending on March 25, 2025.

See also: Benzinga IPO Calendar

About BioAge Labs, Inc

BioAge Labs, Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.